- Home
- SURG vs BRNS Comparison
SURG vs BRNS Comparison
Compare SURG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- BRNS
- Stock Information
- Founded
- SURG 2006
- BRNS 2016
- Country
- SURG United States
- BRNS United Kingdom
- Employees
- SURG N/A
- BRNS N/A
- Industry
- SURG Advertising
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- BRNS Health Care
- Exchange
- SURG Nasdaq
- BRNS Nasdaq
- Market Cap
- SURG 56.1M
- BRNS 48.3M
- IPO Year
- SURG N/A
- BRNS 2021
- Fundamental
- Price
- SURG $2.97
- BRNS $1.10
- Analyst Decision
- SURG Strong Buy
- BRNS Strong Buy
- Analyst Count
- SURG 1
- BRNS 1
- Target Price
- SURG $9.00
- BRNS $3.00
- AVG Volume (30 Days)
- SURG 107.6K
- BRNS 37.9K
- Earning Date
- SURG 11-11-2025
- BRNS 11-05-2025
- Dividend Yield
- SURG N/A
- BRNS N/A
- EPS Growth
- SURG N/A
- BRNS N/A
- EPS
- SURG N/A
- BRNS N/A
- Revenue
- SURG $36,461,935.00
- BRNS $14,969,000.00
- Revenue This Year
- SURG $47.01
- BRNS N/A
- Revenue Next Year
- SURG $128.15
- BRNS N/A
- P/E Ratio
- SURG N/A
- BRNS N/A
- Revenue Growth
- SURG N/A
- BRNS 1766.46
- 52 Week Low
- SURG $1.05
- BRNS $0.64
- 52 Week High
- SURG $3.47
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- SURG 64.25
- BRNS 42.78
- Support Level
- SURG $2.77
- BRNS $1.08
- Resistance Level
- SURG $2.83
- BRNS $1.20
- Average True Range (ATR)
- SURG 0.14
- BRNS 0.09
- MACD
- SURG 0.05
- BRNS -0.01
- Stochastic Oscillator
- SURG 98.25
- BRNS 7.41
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.